Singone Cross-linked Sodium Hyaluronate For Intra-Articular Single lnjection
Indication
It is indicated for the treatment of pain in osteoarthritis (OA) of the knee in p atients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics (e.g., acetaminophen).
Single injection
convenience of a single injection compared to multiple visits to the physician.
High molecular weight
Molecular weight of raw materials≥2.1 M Daltons.
Long-lasting
cross-linked HA(singlink patented technology) with pain relief over 6 months.
100% biocompatibility
highly concentrated, non-animal sourced HA.
Contact Us Now
Send your inquiry. Get a free quote. Increase your sales!
